News
Despite the price drop, BNB is seeing growing corporate adoption, with several companies announcing plans to invest hundreds ...
Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...
Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.
Windtree Therapeutics has said it is raising another $520 million to buy up BNB, the fifth-largest digital coin, to put on ...
Windtree Therapeutics has entered agreements to raise up to $520 million for BNB cryptocurrency acquisition, with a total commitment nearing $700 million. The company plans to direct 99% of funds ...
Liminatus Pharma and CEA Industries announce $1B combined BNB treasury allocations, driving exchange token market to $161B cap.
BNB coin price has surged following a treasury strategy announcement from Windtree Therapeutics, a Nasdaq-listed clinical-stage biotech firm.
BNB (BNB) price is down slightly to trade at $771 on Friday, after correcting from its new record high of $809, reached on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results